The Government’s Work, Heath and Disability Consultation closes at the end of this week. The Haemophilia Society has been working on a response to the series of consultation questions but would like further input from members on issues to raise or specific situations to highlight. Overall, we are pleased that
Tagged as: guidance
APPG on Haemophilia and Contaminated Blood 8th February
The APPG on Haemophilia and Contaminated Blood met last week on the 8th February to discuss the Agenda below. Agenda Introductions and Apologies Update on the call for a Hillsborough-style independent panel Passporting to benefits for those affected by the Scandal Developments in the implementation of the new Support Scheme
Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation
New guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) advises that all hepatitis C patients should be screened for hepatitis B before starting treatment with new Direct-acting Antivirals (DAAs). If patients are infected with both viruses this does not preclude treatment but this should be monitored and managed.